Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:CLVS
Date11/2011
Raised$130M
Post IPO Valuation

General Information

Websiteclovisoncology.com
Twitter@clovisoncology
CategoryBioTech
Employees
Founded2009
DescriptionOncology Compound Licencing Company

Offices

HQ
2525 28th Street
Suite 100
Boulder, CO, 80301
USA

People

Founder, CEO & President
Founder
Board Member
Board of Directors
Boards of Directors
Executive Vice President and Chief Financial Officer
Senior Vice President, Commercial
Executive Vice President, Technical Operations and Chief Regulatory Officer
Show All People

Acquisitions

Investments

Funding

TOTAL $357M
FUNDING TOTAL $357M
Private Equity, 5/2009
Domain Associates
New Enterprise Associates
Versant Ventures
Aberdare Ventures
Abingworth
Frazier Healthcare Ventures
ProQuest Investments
$145M
Convertible Note, 6/2011
$20M
Private Equity, 11/2013
$192M

Tags

Clovis Oncology

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets.

Recent Milestones

Videos

Screenshots

Products

Clovis Oncology

Add some content to this product

Stock Price

Sources

  1. Clovis Oncology Acquires EOS (Ethical Oncology Science) S.p.A. to Gain Rights to Lucitanib, a Unique Dual-Selective Phase II FGFR/VEGFR Inhibitor (phx.corporate-ir.net) [edit]
  2. Avila spears $4M in milestone payment from Clovis (masshightech.com) [edit]
  3. Clovis Oncology (Boulder, CO) an entity focused on licensing or acquiring rights to oncology compounds in all stages of clinical development (onbiovc.com) [edit]
  4. SEC (sec.gov) [edit]
  5. SEC (sec.gov) [edit]
Edit This Page
Last Edited 1/31/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy